your badges 52W Range $1–$7 0% of range Analyst Rating BUY 21 analysts Price Target $5 +537% upside P/E · ROE -45.9% Net Profit Margin ·

CMPX Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range

03
Price $0.86
Market Cap (MRQ) $154M
Revenue $0
ROE -45.9%
52W Range $1–$7

CMPX Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view

04
range
bars

Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.

10-Year Performance Revenue, net income, margins and EPS trends

06
Revenue$0
2023-12-31 → 2025-12-31
Free Cash Flow$-49M
2020-12-31 → 2025-12-31
Net margin·
2024-12-31 → 2024-12-31
Valuation & Ratios 07–12

Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?

Metric 5Y trend CMPX 5Y avg Peer Median Verdict
P/B (MRQ) 0.95Y avg ≈2.7 ≈2.7 2.7 Fair value
Price / FCF (TTM) -2.75Y avg ≈-12.5 ≈-12.5 · ·
Price / Cash Flow (TTM) -2.75Y avg ≈-12.7 ≈-12.7 · ·
Price / Tangible Book 0.85Y avg ≈2.7 ≈2.7 · ·

Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.

value · ≈ 5Y avg · industry median · verdict relative to median

Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date

14
Avg Surprise 1.6%
Next Report Nov 03, 2026
PeriodReportEPS ActualEPS EstSurprise
June 30, 2026 Aug 10, 2026 $-0.13 $-0.11 -17.6%
March 31, 2026 May 13, 2026 $-0.10 $-0.10 0.10%
Dec. 31, 2025 $-0.09 $-0.09 2.4%
Sept. 30, 2025 $-0.08 $-0.14 43.0%
June 30, 2025 $-0.14 $-0.12 -12.3%
March 31, 2025 $-0.12 $-0.11 -6.0%

Full Fundamentals All metrics by year — income statement, balance sheet, cash flow

15
Income Statement 14
Metric Trend 202520242023
Revenue $0$850.0K$0
R&D Expense $56M$42M$38M
SG&A Expense $17M$15M$12M
Operating Expenses $73M$57M$50M
Operating Income $-73M$-57M$-50M
Interest Income $6M$7M$8M
Other Non-op $6M$7M$8M
Pretax Income ··$-42M
Income Tax $0$0$0
Net Income $-66M$-49M$-42M
EPS (Basic) $-0.42$-0.36$-0.33
Shares (Basic) 157,695,000137,384,000127,027,000
Shares (Diluted) ·137,400,000·
EBITDA $-73M$-57M$-50M
Balance Sheet 20
Metric Trend 202520242023
Cash & Equivalents $31M$43M$24M
Short-term Investments $178M$83M$128M
Prepaid Expense $913.0K$6M$1M
Current Assets $210M$133M$154M
PP&E (Net) $102.0K$353.0K$898.0K
PP&E (Gross) $7M$7M$7M
Accum. Depreciation $7M$6M$6M
Other Non-current Assets ·$568.0K$320.0K
Total Assets $220M$140M$157M
Accounts Payable $2M$2M$4M
Accrued Liabilities $11M$6M$3M
Current Liabilities $14M$9M$8M
Capital Leases $9M$6M$536.0K
Total Liabilities $23M$15M$8M
Common Stock $18.0K$14.0K$13.0K
Retained Earnings $-431M$-365M$-315M
AOCI $280.0K$210.0K$37.0K
Stockholders' Equity $197M$125M$149M
Liabilities + Equity $220M$140M$157M
Shares Outstanding 178,324,000137,820,000127,668,000
Cash Flow 10
Metric Trend 202520242023
D&A $276.0K$589.0K$699.0K
Stock-based Comp $8M$9M$6M
Operating Cash Flow $-49M$-45M$-41M
CapEx $25.0K$44.0K$30.0K
Investing Cash Flow $-93M$47M$27M
Stock Issued $138M$18M$3M
Net Stock Activity $138M$18M$3M
Financing Cash Flow $130M$17M$3M
Net Change in Cash $-13M$19M$-11M
Free Cash Flow $-49M$-45M$-41M
Profitability 6
Metric Trend 202520242023
Operating Margin ·-6661.8%·
Net Margin ·-5808.8%·
EBITDA Margin ·-6661.8%·
ROA -36.9%-33.2%-23.8%
ROE -45.9%-37.5%-27.5%
ROIC ··-33.9%
Liquidity & Solvency 2
Metric Trend 202520242023
Current Ratio 15.015.019.7
Quick Ratio 15.014.319.5
Efficiency 1
Metric Trend 202520242023
Asset Turnover 0.00.0·
Per Share 2
Metric Trend 202520242023
Book Value / Share $1.10$0.91$1.16
Cash / Share $0.17$0.32$0.19
Valuation (TTM) 8
Metric Trend 202520242023
Revenue TTM $0$850.0K$0
Net Income TTM $-66M$-49M$-42M
Market Cap $958M$200M$199M
P/S ·235.1·
P/B 4.91.61.3
P / Tangible Book 4.91.61.3
P / Cash Flow -19.5-4.5-4.9
P / FCF -19.5-4.5-4.9

Most recent period on the left · null values shown as ·

Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years

16
Metric 2025-12-312024-12-312023-12-312022-12-312021-12-31
Revenue $0 $850.0K $0 · ·
Operating Margin % · -6661.8% · · ·
Net Income $-66M $-49M $-42M $-39M $-82M

Institutional owners (13F) 225 filers · $404.9M total · As of June 30, 2026

17

Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.

Holders 225
Value held $404.9M
New positions 65
Exited positions 44
Institutional activity — Q2 2026 vs prior quarter
New positions Exited positions Increased Decreased Net shares change
65 (+9 vs prior Q) 44 (+25 vs prior Q) 85 (+13 vs prior Q) 46 (-1 vs prior Q) -7.0M

Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.

Institution Value Shares % of tracked 13F Type
VANGUARD GROUP INC $43,219,768 8,048,374 10.67% Shares
TANG CAPITAL MANAGEMENT LLC $39,399,813 17,990,782 9.73% Shares
ORBIMED ADVISORS LLC $33,331,787 15,219,994 8.23% Shares
MONTANOVA CAPITAL, LLC $30,881,538 14,101,159 7.63% Shares
BlackRock, Inc. $24,707,100 11,281,781 6.10% Shares
STATE STREET CORP $21,798,500 9,953,653 5.38% Shares
ENAVATE SCIENCES GP, LLC $17,056,049 7,788,150 4.21% Shares
Vivo Capital, LLC $16,987,961 7,757,060 4.20% Shares
VANGUARD CAPITAL MANAGEMENT LLC $13,400,133 6,118,782 3.31% Shares
Palo Alto Investors LP $12,771,670 5,831,813 3.15% Shares
MILLENNIUM MANAGEMENT LLC $10,322,011 4,713,247 2.55% Shares
GEODE CAPITAL MANAGEMENT, LLC $8,357,450 3,815,189 2.06% Shares
VANGUARD PORTFOLIO MANAGEMENT LLC $8,258,560 3,771,032 2.04% Shares
Qube Research & Technologies Ltd $8,075,601 3,687,489 1.99% Shares
Blue Owl Capital Holdings LP $7,936,726 3,624,076 1.96% Shares
CITADEL ADVISORS LLC $7,819,776 3,570,674 1.93% Shares
GOLDMAN SACHS GROUP INC $7,732,890 3,531,000 1.91% Shares
Rock Springs Capital Management LP $7,719,595 3,524,929 1.91% Shares
AQR CAPITAL MANAGEMENT LLC $7,685,011 3,509,137 1.90% Shares
Birchview Capital, LP $3,668,250 1,675,000 0.91% Shares
KINGDON CAPITAL MANAGEMENT, L.L.C. $3,066,000 1,400,000 0.76% Shares
Fisher Asset Management, LLC $3,048,238 1,391,890 0.75% Shares
ROYCE & ASSOCIATES LP $2,927,548 1,336,780 0.72% Shares
FMR LLC $2,654,709 1,212,196 0.66% Shares
ADAGE CAPITAL PARTNERS GP, L.L.C. $2,598,435 1,186,500 0.64% Shares
NORTHERN TRUST CORP $2,498,603 1,140,914 0.62% Shares
Atle Fund Management AB $2,296,418 1,048,593 0.57% Shares
Nuveen, LLC $2,213,130 1,010,562 0.55% Shares
Squarepoint Ops LLC $2,206,440 1,007,507 0.54% Shares
VANGUARD FIDUCIARY TRUST CO $2,192,054 1,000,938 0.54% Shares
Blackstone Inc. $1,970,860 899,936 0.49% Shares
FIRST TRUST ADVISORS LP $1,767,338 807,004 0.44% Shares
JPMORGAN CHASE & CO $1,705,102 789,399 0.42% Shares
KVP Capital Advisors, LP $1,688,490 771,000 0.42% Shares
MORGAN STANLEY $1,610,058 735,186 0.40% Shares
CITIGROUP INC $1,563,457 713,907 0.39% Shares
UBS Group AG $1,560,951 712,763 0.39% Shares
Burkehill Global Management, LP $1,533,000 700,000 0.38% Shares
Point72 Asset Management, L.P. $1,503,604 686,577 0.37% Shares
ACUTA CAPITAL PARTNERS, LLC $1,303,516 595,213 0.32% Shares
BANK OF AMERICA CORP /DE/ $1,241,553 566,919 0.31% Shares
CM Management, LLC $1,204,500 550,000 0.30% Shares
DIMENSIONAL FUND ADVISORS LP $1,184,772 541,178 0.29% Shares
Connor, Clark & Lunn Investment Management Ltd. $1,147,072 523,777 0.28% Shares
ALLIANCEBERNSTEIN L.P. $856,345 161,880 0.21% Shares
Artia Global Partners LP $839,208 383,200 0.21% Shares
WELLINGTON MANAGEMENT GROUP LLP $829,324 378,687 0.20% Shares
ArrowMark Colorado Holdings LLC $798,785 364,742 0.20% Shares
Bank of New York Mellon Corp $768,760 351,032 0.19% Shares
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC $738,706 139,642 0.18% Shares

Show all 225 institutional owners →

Activists & 5%+ owners 5 positions

18

Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.

Filer Filed Stake Status Purpose Filing
Commander Aggregator, LP, Enavate Sciences, LP, Enavate Sciences GP, LLC, Enavate Sciences Holdings, LLC Aug. 18, 2025 4.50% Amendment · SEC
ORBIMED ADVISORS LLC, ORBIMED CAPITAL GP V LLC ×7 filings Aug. 15, 2025 8.90% Amendment · SEC
Undisclosed reporting person Nov. 14, 2022 · Initial filing Passive investment SEC
Philip Ferneau, Vox Health Fund, L.P., Borealis Capital Partners IV, LLC, Borealis Granite Fund, L.P., Borealis Capital Partners III, LLC June 26, 2020 · Initial filing · SEC
Thomas J. Schuetz June 26, 2020 · Initial filing · SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.

Company insiders 19 insiders · 8 officers · 13 directors

19
Insider Role Last activity Shares owned Buys 12m Sells 12m Net 12m
Thomas J. Schuetz CHIEF EXECUTIVE OFFICER Feb. 8, 2026 F 6,603,336 0 0 $0
Vered Bisker-Leib CHIEF EXECUTIVE OFFICER Feb. 8, 2024 F 3,124,426 0 0 $0
Barry Shin CFO Jan. 2, 2026 A 525,000 0 0 $0
Neil Lerner Chief Accounting Officer Oct. 1, 2026 P 420,000 3 0 $49,600
Jonathan Anderman General Counsel April 29, 2026 P 196,000 1 0 $47,250
Arjun Prasad Chief Commercial Officer Jan. 2, 2026 A · 0 0 $0
Cynthia Sirard Chief Medical Officer Jan. 2, 2026 A · 0 0 $0
Susan Kalled Chief Scientific Officer Feb. 18, 2022 A · 0 0 $0
James P Boylan Director Jan. 2, 2026 A · 0 0 $0
Philip Ferneau Director Jan. 2, 2026 A 400,280 0 0 $0
Ellen Chiniara Director Jan. 2, 2026 A · 0 0 $0
GORDON CARL L Director Jan. 2, 2026 A 0 0 0 $0
Mary Ann Gray Director Jan. 2, 2026 A · 0 0 $0
Richard S Lindahl Director Jan. 2, 2026 A · 0 0 $0
David M Wurzer Director Feb. 8, 2023 A · 0 0 $0
Brett Kaplan Director Feb. 18, 2022 A · 0 0 $0
Stephen P Squinto Director Feb. 18, 2022 A · 0 0 $0
Miranda Jayne Toledano Director June 25, 2021 A 1,791,549 0 0 $0
Julie Sunderland Director June 19, 2020 P 2,502,025 0 0 $0

Insiders from SEC Form 3/4/5 filings; net = open-market P/S only

ETF ownership Held by 20 ETFs

20

Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.

Fund Weight Units As of Source
BBC · ETFis Series Trust I 0.63% 153,110 NS July 31, 2026 N-PORT
LABU · Direxion Shares ETF Trust 0.09% 232,413 NS July 31, 2026 N-PORT
IWC · iShares Trust 0.06% 445,711 SH Sept. 11, 2026 Daily
PWS · Pacer Funds Trust 0.03% 3,175 NS July 31, 2026 N-PORT
VTWV · VANGUARD SCOTTSDALE FUNDS 0.02% 114,090 SH Aug. 19, 2026 Daily
VTWO · VANGUARD SCOTTSDALE FUNDS 0.01% 754,118 SH Aug. 19, 2026 Daily
IWM · iShares Trust 0.01% 3,395,394 SH Sept. 11, 2026 Daily
RSSL · Global X Funds 0.01% 62,629 NS July 31, 2026 N-PORT
FHLC · FIDELITY COVINGTON TRUST 0.00% 37,125 NS July 31, 2026 N-PORT
DFAS · Dimensional ETF Trust 0.00% 101,119 NS July 31, 2026 N-PORT
DFAC · Dimensional ETF Trust 0.00% 166,283 NS July 31, 2026 N-PORT
ITOT · iShares Trust 0.00% 244,937 SH Sept. 11, 2026 Daily
IWV · iShares Trust 0.00% 34,242 SH Sept. 3, 2026 Daily
DFAU · Dimensional ETF Trust 0.00% 19,635 NS July 31, 2026 N-PORT
DFUS · Dimensional ETF Trust 0.00% 13,305 NS July 31, 2026 N-PORT
VXF · VANGUARD INDEX FUNDS 0.00% 1,793,659 SH Aug. 19, 2026 Daily
VTI · VANGUARD INDEX FUNDS 0.00% 4,190,754 SH Aug. 19, 2026 Daily
VTHR · VANGUARD SCOTTSDALE FUNDS 0.00% 11,073 SH Aug. 19, 2026 Daily
VHT · VANGUARD WORLD FUND 0.00% 257,838 SH Aug. 19, 2026 Daily
IWN · iShares Trust · 1,205,272 SH Sept. 11, 2026 Daily

CMPX Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside

21
rating · 21 analysts BUY
Median target $6.00 +600.4%
9 42.9% Strong Buy
10 47.6% Buy
2 9.5% Hold
0 0.0% Sell
0 0.0% Strong Sell

12-Month Price Target

11 analysts · 2026-10-01

Mean target $5.45 +536.7%

← Below all targets Current price $0.86
Low$1.00 Mean$5.45 High$12.00

Peer comparison (GICS sub-industry) Key metrics vs sector peers

22

FY basis, prices as of each company's last fiscal year-end close.

Ticker Market Cap P/E Rev YoY Net Margin ROE Gross Margin
CMPX $958M · · · -45.9% ·
ORGO $658M 34.5 17.0% 6.6% 13.9% ·
DTIL $100M -1.2 -50.1% -133.4% -72.4% ·
ALXO $61M -0.6 · · -225.0% ·
VYGR $232M -1.9 -49.5% -296.5% -54.4% ·
AVXL · -16.5 -36.1% -991.4% · ·
TNXP $200M -1.1 29.8% -946.2% -60.0% ·
TARA $286M -4.0 · · -33.7% ·
PEPG $448M -3.1 · · -82.0% ·
NBP $1.06B -19.0 · · -21.4% ·
NERV $174M -0.1 · · 339.5% ·

Latest News Recent headlines mentioning this company

23
Compass Therapeutics, Inc. (CMPX) Up 200% Year-on-Year Yahoo Finance · 5 months, 1 week ago Notable Tuesday Option Activity: BA, GOOG, CMPX Nasdaq · 6 months ago

My Metrics Your personal watchlist — selected rows from Full Fundamentals

26

Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.

Your selection is saved and follows you across all tickers.

Source: SEC 10-Q filed Aug 6, 2026